Posted on May 1, 2026

Enrolment Update- May 2026

We’re excited to provide you with our latest enrolment update. As of May 1st, 2026, the PERFORM trial has officially reached 30 enrolled patients. This momentum has been amazing, and we want to extend a big thank you to Dr. Kenneth Gundle at the Oregon Health and Science University Hospital, Dr. Andreas Leithner at the Medical University Graz, Dr. Ricardo Becker at the Hospital de Clínicas de Porto Alegre, Dr. Christopher Johnson at the Parkview Packnett Family Cancer Institute, and their research teams for their contributions over the past month. We are delighted to recognize Dr. Andreas Leithner and the team at the Medical University of Graz for successfully completing their first enrolment in the PERFORM trial and for being the first European site to open for enrolment! With everyone’s collaboration, we are confident we can hit 50 enrolments by the end of the year and maybe even surpass it. Every patient enrolled brings us one step closer to answering meaningful research questions and advancing care for MBD patients worldwide.